These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34288578)

  • 21. Pharmacokinetics, Bioequivalence and Safety of Cloperastine in Chinese Healthy Subjects Under Fasting and Postprandial Conditions.
    Luo HY; Long HZ; Zhou ZW; Xu SG; Li FJ; Cheng Y; Wen DD; Deng P; Gao LC
    Drugs R D; 2022 Dec; 22(4):311-320. PubMed ID: 36369609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioequivalence study of two formulations of afatinib dimaleate tablets in healthy subjects under fasting conditions: A randomized, open-label, single-dose, crossover trial.
    Liu Y; Lü L; Xu M; Tao J; Ning Y; Shi Y; Dong Y; Cao Q; Ma J; Qiu Y
    Int J Clin Pharmacol Ther; 2024 Oct; 62(10):479-485. PubMed ID: 39157917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioequivalence and safety evaluation of two preparations of metformin hydrochloride sustained-release tablets (Boke
    Sun ML; Liu C; Bai HH; Wei YL; Zhang W; Liu HJ; Li YJ; Liu L; Wang Y; Tong YX; Gao Q; Liu QY; Wang X
    Ann Med; 2022 Dec; 54(1):2626-2635. PubMed ID: 36135935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and Bioequivalence of 2 Immediate-Release Tofacitinib Tablet Formulations in Chinese Healthy Volunteers Under Fasting and Fed Conditions.
    Li X; Liu L; Deng Y; Li Y; Zhang P; Wang Y; Xu B; Feng J; Huang L
    Clin Pharmacol Drug Dev; 2021 May; 10(5):535-541. PubMed ID: 32770665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and Bioequivalence of Single-Oral-Dose Linagliptin: A Randomized, 2-Period Crossover Trial in Chinese Healthy Subjects Under Fasting and Fed Conditions.
    Li Y; Zhang X; Qi L; Tong Y; Bai H; Liu J; Liu Y; Chen Y; Wang X
    Clin Pharmacol Drug Dev; 2022 Oct; 11(10):1157-1164. PubMed ID: 35514254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and Bioequivalence of Fudosteine in Healthy Chinese Volunteers Under Fasting and Fed Conditions: A 4-Way Replicate Crossover Study.
    Zhu M; Tao Y; Pu J; Zhao H; Wan L; Zhang P; Tang C
    Clin Pharmacol Drug Dev; 2023 Jan; 12(1):30-37. PubMed ID: 35794358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioequivalence Study Of A Fixed-Dose Combination Tablet Containing Melitracen 10 mg And Flupentixol 0.5 mg In Healthy Chinese Volunteers Under Fasted And Fed Conditions.
    Wu L; Xu C; Wu G; Zhou H; Lv D; Zhai Y; Huang Y; Tang W; Li F; Shentu J
    Drug Des Devel Ther; 2019; 13():3331-3342. PubMed ID: 31571834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and bioequivalence evaluation of two oral formulations of cotrimoxazole tablets in healthy Chinese volunteers under fasting conditions.
    Zuo X; Zhao X; Shi J; Zhang T
    BMC Pharmacol Toxicol; 2024 Feb; 25(1):23. PubMed ID: 38414087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioequivalence Study of Atenolol Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions.
    Li Y; Huang Y; Fu X; Xia J; Su J; Gu W; Liu W; Jian J; Xu Z
    Clin Pharmacol Drug Dev; 2024 Aug; 13(8):870-875. PubMed ID: 38742472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial.
    Yang L; Zhang L; Luo Z
    Drug Des Devel Ther; 2023; 17():2369-2381. PubMed ID: 37600497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioequivalence of Two Linezolid Tablets Under Fed and Fasting Conditions in Healthy Chinese Individuals.
    Wang S; Guo S; Han Y; Ni S; Wu F; Dai Y; Xia Q; Yang Y; Zhao X
    Clin Pharmacol Drug Dev; 2022 Dec; 11(12):1481-1488. PubMed ID: 36000293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioequivalence study of dacomitinib and Vizimpro® in healthy Chinese volunteers under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial.
    Yang X; Li J; Zhang T; Xia Q; Zhang W; Cui Y; He W
    Clin Transl Sci; 2023 Dec; 16(12):2591-2603. PubMed ID: 37786330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioequivalence of cefalexin in healthy Chinese subjects.
    Lv X; Zhong G; Yao H; Wu J; Ye S
    Int J Clin Pharmacol Ther; 2021 Nov; 59(11):725-733. PubMed ID: 34448694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and Bioequivalence of a Generic Fixed-Dose Combination Tablet of Metformin Hydrochloride/Vildagliptin Versus a Branded Product in Healthy Chinese Subjects Under Fed and Fasting Conditions.
    Ye L; Li B; Ling N; Gao Y; Tao X; Cai S; Wang Y; Chen S; Wang F
    Clin Pharmacol Drug Dev; 2022 Jan; 11(1):63-70. PubMed ID: 34273258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and bioequivalence of two methylprednisolone tablet formulations in healthy Chinese subjects under fasting and fed conditions.
    Fan L; Zhang P; Gan C; Huang Q; Shen Z; Xiao X; Yang Y; Qiu D; Mai G; Shentu J
    Int J Clin Pharmacol Ther; 2023 Jan; 61(1):37-44. PubMed ID: 36278293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single-dose, randomized, open-label, four-period, crossover equivalence trial comparing the clinical similarity of the proposed biosimilar rupatadine fumarate to reference Wystamm
    Lin S; Lou Y; Hao R; Shao Y; Yu J; Fang L; Bao M; Yi W; Zhang Y
    Front Pharmacol; 2024; 15():1328142. PubMed ID: 38828454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A crossover study to evaluate the pharmacokinetics and bioequivalence of hydroxychloroquine tablets in healthy Chinese subjects.
    Feng J; Kuang SY; Wan JH; Li R; Zhu YJ; Cai BL; Guan L; Zhang Z
    Int J Clin Pharmacol Ther; 2024 Jun; 62(6):284-292. PubMed ID: 38577751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and Bioequivalence of 2 Olanzapine Orally Disintegrating Tablet Products in Healthy Chinese Subjects Under Fed and Fasting Conditions.
    Fan L; Zhang L; Zheng H; Cheng J; Hu Y; Liu J; Fan H
    Clin Pharmacol Drug Dev; 2020 Jul; 9(5):593-601. PubMed ID: 32413238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioequivalence study of two formulations of flupirtine maleate capsules in healthy male Chinese volunteers under fasting and fed conditions.
    Liu Y; Huo H; Zhao Z; Hu W; Sun Y; Tang Y
    Drug Des Devel Ther; 2017; 11():3441-3448. PubMed ID: 29238169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients with Colorectal or Breast Cancer Under Fed Conditions: A Multicenter, Randomized, Open-Label, Three-Period, and Reference-Replicated Crossover Study.
    Wang CJ; Li T; Lin PP; Tao Y; Jiang X; Li X; Wen Q; Cao Y
    Adv Ther; 2021 Sep; 38(9):4798-4814. PubMed ID: 34347254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.